Abstract
This case describes a 53-year-old male patient presenting with right-sided abdominal pain and acute kidney injury (AKI) who retained intravenous (IV) contrast within the ureter from a previous image 24 hours prior at a different hospital that was initially mistaken for a calcified ureteral stent after presenting to a different hospital without the patient initially disclosing his previous hospital stay. This created diagnostic uncertainty and prompted subspecialty consultations for a device the patient had never received. The patient subsequently passed a ureteral calculus with resolution of symptoms and improvement in renal function. This case highlights the importance of recognizing residual IV contrast as a potential mimic of foreign bodies on computed tomography (CT), particularly in patients with recent contrast-enhanced studies.
Keywords: computed tomography, radiology, residual contrast, ureteral stent, urolithiasis
Introduction
Noncontrast enhanced computed tomography (CT) is the gold standard for evaluating ureterolithiasis. However, radiographic mimics may complicate interpretation and clinical decision-making, like this case. Residual intravenous (IV) contrast layering within the ureter has been described as a diagnostic pitfall, occasionally resembling calcifications or indwelling ureteral stents [1-3]. IV contrast may persist within the ureter because delayed excretion occurs when urinary flow is obstructed or renal function is impaired, allowing contrast material to pool and layer rather than clear normally. Recognition of this phenomenon is essential to avoid unnecessary interventions such as ureteroscopy with stent removal. This procedure carries risks such as anesthesia complications, ureteral injury or perforation, infection, bleeding. We present a case of ureterolithiasis in which retained contrast was initially mistaken for a calcified ureteral stent.
Case presentation
A 53-year-old male flight attendant with no significant past medical history presented to the emergency department in Las Vegas with three days of right-sided abdominal pain radiating to the groin. Symptoms began during a flight from Japan to California. He reported several episodes of vomiting on the flight, which subsequently resolved. He denied fever, chills, and endorsed dysuria and pain radiating to his groin.
On arrival, the patient was hemodynamically stable, afebrile, and in mild distress. Physical examination revealed right lower quadrant and flank tenderness without guarding or rebounding. Initial laboratory results revealed an elevated creatinine with no baseline level for reference, normal blood urea nitrogen, leukocytosis, lactic acid level, and hypokalemia (Table 1). Urinalysis demonstrated blood, trace ketones, and rare mucous, but no leukocyte esterase or nitrites as shown in Tables 2-3. Blood and urine cultures obtained were negative.
Table 1. Laboratory values.
| Lab | Patient values | Reference values |
| Creatinine | 2.24 mg/dL | 0.7-1.30 mg/dL |
| Blood urea nitrogen | 17 mg/dL | 7-18 mg/dL |
| White blood cells | 12.93 × 10³/µL | 3.18-12.74 × 10³/µL |
| Potassium | 3.3 mmol/L | 3.5-5.1 mmol/L |
| Lactic acid | 0.8 mmol/L | 0.5-2.2 mmol/L |
Table 2. Macroscopic urinalysis.
| Macroscopic urinalysis | Patient values | Reference values |
| Color | Yellow | Yellow |
| Ketones | Trace | Negative |
| Blood | 3+ | Negative |
| Nitrite | Negative | Negative |
| Leukocyte esterase | 2+ | Negative |
Table 3. Microscopic urinalysis.
HPF: high power field
| Microscopic urinalysis | Patient values | Reference values |
| White blood cells | 11/HPF | 0-5/HPF |
| Red blood cells | 6/HPF | 0-2/HPF |
| Bacteria | 1+/HPF | none |
| Squamous epithelium | None | 0-5/HPF |
| Mucous | Rare | None |
Noncontrast enhanced CT imaging of the abdomen and pelvis demonstrated right hydroureteronephrosis with a linear high-density structure in the distal ureter, initially concerning for a migrated or calcified ureteral stent (Figure 1). The linear high-density structure measured 244 Hounsfield units (HU). The patient denied any history of ureteral stent placement. Urology and nephrology were consulted to help evaluate the calcified stent. The patient was admitted for pain control, renal function monitoring, and management of acute kidney injury (AKI). He was treated with IV lactated Ringer's fluid, tamsulosin 0.4 mg orally daily, and analgesics, including morphine 2-4 mg IV every four hours as needed and hydrocodone-acetaminophen 10-325 mg orally every four hours as needed until he spontaneously passed the stone later during his hospital stay. Empiric ceftriaxone 1 g IV daily was initiated due to leukocytosis and flank pain.
Figure 1. Noncontrast enhanced CT imaging of the abdomen and pelvis demonstrating right hydroureteronephrosis (A,B) with a linear high-density structure in the distal ureter extending into the bladder concerning for ureteral stent (C-F).
Renal ultrasound revealed mild right hydronephrosis. During hospitalization, the patient reported spontaneous passage of a stone and rapid improvement in symptoms. The stone was visualized via a urinary strain. His creatinine improved from 2.24 mg/dL on admission to 0.93 mg/dL by discharge. Repeat noncontrast CT demonstrated persistent but improving hydronephrosis with no evidence of a stent or retained foreign body. The patient was discharged in stable condition, tolerating diet, afebrile, and pain-free.
Upon further review, it was noted that the patient had undergone contrast-enhanced CT imaging in San Francisco one day prior to presentation of the current visit. An addendum to the CT report clarified that the hyperdense structure likely represented retained IV contrast in the ureter at the level of the ureterovesical junction.
Discussion
This case illustrates an important diagnostic complication in the evaluation of suspected ureterolithiasis. Residual IV contrast may persist within the urinary tract for hours following administration, particularly in the setting of obstruction, and can closely mimic a linear ureteral stent on CT. In this case, the finding raised concern for a migrated or calcified stent, prompting subspecialty consultation. Only after correlation with recent imaging was the true etiology confirmed.
The patient’s AKI was likely multifactorial, driven by both obstructive uropathy and recent contrast exposure. Obstructive uropathy-related AKI typically results from impaired urinary drainage, causing increased intratubular pressure and creatinine rise, which often improves promptly after decompression. In contrast, contrast-associated AKI generally presents within 24-48 hours of exposure due to renal vasoconstriction and tubular toxicity, and recovery may be more gradual. In this case, renal function normalized, with a creatinine of 0.93 mg/dL on discharge. Considering the patient had conservative management with IV fluids, analgesics, and empiric antibiotics that were discontinued once culture results were negative, supports obstructive AKI as the dominant contributor to the renal dysfunction of the patient.
With presentations such as this patient, forgotten ureteral stent syndrome is at the top of the differential [4]. This phenomenon occurs when a patient has a previous history of stent placement left beyond their intended duration. The stent subsequently becomes calcified and leads to complications that are similar to other types of obstructive uropathy.
To differentiate calcified ureteral stents, urinary calculi, and retained contrast, quantitative assessment of radiologic attenuation using HU can be helpful. On noncontrast CT, true urinary calculi typically demonstrate focal high attenuation, commonly exceeding 300 HU and often greater than 1000 HU for calcium-based stones. In contrast, metallic or polymer ureteral stents exhibit markedly higher attenuation, with reported in vitro values ranging from approximately 1600 to 2600 HU. Retained iodinated contrast demonstrates intermediate to variably high attenuation depending on concentration and timing and typically conforms to the tubular anatomy of the ureter rather than appearing as discrete, rounded calcific foci. The patient's retained contrast had 244 HU, which is more consistent with contrast rather than a stone. Evaluation using bone-window settings may further aid in distinguishing ureteral stents, which remain hyperdense, from urinary calculi [5,6].
This case emphasizes the importance of obtaining a thorough clinical history, including prior imaging, when interpreting CT findings. Misinterpretation of retained contrast as a ureteral stent led to an initial recommendation for urology to perform ureteroscopy with presumed stent removal. This procedure carries risks such as anesthesia complications, ureteral injury or perforation, infection, and bleeding. Recognizing that no stent had been placed avoided an unnecessary and potentially harmful surgery.
Conclusions
Retained IV contrast within the ureter is an under recognized mimic of indwelling devices such as ureteral stents on noncontrast CT imaging especially in patients with recent contrast exposure in the setting of ureteral obstruction. Awareness of this phenomenon is essential to avoid diagnostic errors and unnecessary interventions such as ureteroscopy with stent removal. Careful review of prior imaging and clinical correlation can help distinguish true foreign bodies from contrast-related artifacts.
Disclosures
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study.
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:
Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.
Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.
Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Author Contributions
Concept and design: Brian R. Beyer
Acquisition, analysis, or interpretation of data: Brian R. Beyer, Ali Haq
Drafting of the manuscript: Brian R. Beyer
Critical review of the manuscript for important intellectual content: Brian R. Beyer, Ali Haq
Supervision: Ali Haq
References
- 1.Complications subsequent to urinary tract stent placement: an overview focusing on the imaging of cancer patients. Corvino A, Basile L, Cocco G, Delli Pizzi A, Tafuri D, Corvino F, Catalano O. Medicina (Kaunas) 2024;60:338. doi: 10.3390/medicina60020338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ureteral stents in urolithiasis. Beysens M, Tailly TO. Asian J Urol. 2018;5:274–286. doi: 10.1016/j.ajur.2018.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Unusual stent after ureteral substitution. A first case. Fiorini G, Pomara G, Manassero F, Mogorovich A, Faggioni L, Selli C. BMC Urol. 2012;12:34. doi: 10.1186/1471-2490-12-34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Forgotten ureteral stents: a systematic review of literature. Wang X, Ji Z, Yang P, Li J, Tian Y. BMC Urol. 2024;24:52. doi: 10.1186/s12894-024-01440-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Distinguishing stent from stone: use of bone windows. Tanrikut C, Sahani D, Dretler SP. Urology. 2004;63:823–826. doi: 10.1016/j.urology.2003.12.041. [DOI] [PubMed] [Google Scholar]
- 6.Computed tomography of urinary calculi. Federle MP, McAninch JW, Kaiser JA, Goodman PC, Roberts J, Mall JC. AJR Am J Roentgenol. 1981;136:255–258. doi: 10.2214/ajr.136.2.255. [DOI] [PubMed] [Google Scholar]

